Nur Liyana Saharudin

  • Pharmacy Department, Hospital Canselor Tuanku Muhriz, Universiti Kebangsaan Malaysia

Pharmacy Staffs’ Perceptions and Opinion on the Drive-Through Pharmacy Service During Covid-19 Pandemic at One of the University Teaching Hospitals in Malaysia

    DOI: 10.52494/OQKB6308
    by Roz Azinur Che Lamin, Ahmad Farid Mohd Jamil, Fadhlul Aqilah Fakhrul Anuar, Dennoel Eku, Nur Liyana Saharudin and Nursyuhadah Othman.
    Vol. 9 No. 1 (2023): Malaysian Journal of Pharmacy / Published: June 30, 2023
    Abstract / Full Text / Download PDF

    Abstract

    Amidst the COVID-19 pandemic that imposed movement control order, most patient had difficulties in collecting the medication. Therefore, drive-thru pharmacy was perceived as the safer and most convenient option to minimal the infection risks. This study aimed to assess the perception and opinion of the pharmacy staffs about the necessities of drive-thru pharmacy service during COVID-19 pandemic. A cross-sectional study was conducted in one of the university teaching hospitals in Malaysia, from February to May 2022. The respondents were among staffs in various pharmacy units. The staff perceptions and opinion of drive-thru pharmacy in preventing the spread of infectious diseases in the community was determined using descriptive analysis while the open-ended question was analyzed thematically. All (n=109) respondents positively acknowledge the importance of drive-thru pharmacy in reducing the risk of virus infection. The staff agreed that drive-thru service is helpful for patients who are busy with their daily routine (n=103; 94.5%), reduces patients’ waiting time for picking up their medications and perceived that drive-thru Services are useful for senior citizen or caretaker (n=95; 87.2%). In conclusion, although 89 (82.0%) of the respondents highlighted the importance of drive-thru service especially during the spike of the COVID-19 pandemic, thirteen respondents (12.0%) raised hesitate to agree with the implementation of this service due to issue of manpower and satisfied with the existing pharmacy value added services (PVAS) at the hospital. Therefore, re-evaluation of the needs of drive-thru pharmacy during COVID-19 pandemic based on the patients and caregivers’ perception should be conducted in future

    An Evaluation of Medication Adherence to Tyrosine Kinase Inhibitors Among Chronic Myeloid Leukemia Patients Underwent Medication Therapy Adherence Clinic in a Malaysian Tertiary Hospital

      DOI: 10.52494/maljpharmv8204
      by Stephanie Wai Yee Tan, Aisya Nabilah Abd Rahman, Chee Lan Lau, Dexter Van Dort, Farah Waheeda Tajurudin, Kiew Bing Pau, Lay Yen Gan, Mei Kuen Yin, Nur Jannah Azman, Nur Liyana Saharudin, Pooi Wan Mok, Poy Kei Lye, Rozita Mohd Idris, Sarah Anne Robert, Sheah Lin Ghan, Shue Hong Kong, Suet Yin Chin and Xin Yun Chua.
      Vol. 8 No. 2 (2022): Malaysian Journal of Pharmacy / Published: December 31, 2022
      Abstract / Full Text / Download PDF

      Abstract

      Introduction: The treatment of chronic phase chronic myeloid leukemia (CML) has changed dramatically within the last two decades with the emergence of tyrosine kinase inhibitors (TKI). Treatment adherence to long-term TKI is pivotal to improving clinical outcomes in CML patients. Objective: To evaluate medication adherence to TKI and contributory variables affecting medication adherence among CML patients underwent Medication Therapy Adherence Clinic (MTAC). Method: This was a single-centre cross-sectional study conducted between January and December 2021. Malaysia Medication Adherence Assessment Tool (MyMAAT) was employed to assess medication adherence among CML MTAC patients. Descriptive statistics were used to summarise adherence information. Fisher’s exact test was performed to examine relationships between TKI adherence level, demographic and clinical variables. Result: Records of 41 patients (61% male, 39% female) at average age of 51 years old (range = 26 to 75) were analysed. They had been taking imatinib (48.8%) and nilotinib (51.2%) for an average of 6.3 years (range = 17 days to 18 years). Overall, 90% of the patients were adherent (MyMAAT score ≥ 54) to their TKI treatment (95% of patients on imatinib, 86% of patients on nilotinib). Medication adherence to TKI was not significantly influenced by demographic variables (i.e. age, gender) and clinical variables (i.e. years on TKI, number of TKI pills per day, type of TKI therapy). Conclusion: Majority of the CML MTAC patients (90%) were adherent to their TKI therapy. Adherence scores were not affected by the demographics and clinical variables investigated in this study. This affirms the role of pharmacists in implementing an individualised and comprehensive intervention strategy.